Studying the evolution of gene regulation at the protein level in primates

研究灵长类动物蛋白质水平基因调控的进化

基本信息

  • 批准号:
    7900345
  • 负责人:
  • 金额:
    $ 5.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-11 至 2011-08-10
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this study is to identify proteins whose expression levels have evolved under natural selection in humans and non-human primates. Variation in gene regulation, both at the transcriptional and translational levels, is thought to be involved in human phenotypic diversity including disease susceptibility, and is hypothesized to have played an important role in human evolution. Although most previous work in this area has focused on mRNA levels, proteins are usually more directly involved in biological processes. Moreover, complex translational regulatory mechanisms can influence protein levels independent of transcript abundance. Therefore, the characterization of variation in protein levels in humans and non-human primates is expected to provide considerable insight into the genomic mechanisms that may have played important roles in our evolutionary history. In this study, I will (i) develop an antibody microarray platform for highthroughput measurements of steady-state protein expression levels in multiple primate species, (ii) use this platform for comparisons of human, chimpanzee (Pan troglodytes), and rhesus macaque (Macaca mulatta) liver, kidney, heart, lung and testis tissues, and (iii) examine ratios of intra- and inter-specific variation to identify proteins whose expression levels have evolved under stabilizing selection across primates or directional selection in the human lineage. These proteins may be involved in human diseases, for example when expression levels are perturbed. Furthermore, proteins with adaptive changes in steady-state expression levels may have been important in the evolution of human-specific traits, which will be explored using analyses of protein functions and patterns of expression and natural selection by tissue. Variation in protein expression levels is thought to be involved in human phenotypic diversity including disease susceptibility, and may have played an important role in human evolution. This study will use highthroughput technologies to compare protein expression levels across five different tissues from humans, chimpanzees, and rhesus macaques, to identify proteins with expression levels that (i) are highly similar among the three primate species, and (ii) have significantly increased or decreased along the human lineage. Such proteins may be involved in human diseases, for example when expression levels are perturbed, and proteins with significant human lineage changes in expression levels may have been important in the evolution of physical traits that are unique to our species.
描述(由申请人提供): 本研究的目的是鉴定在人类和非人类灵长类动物中在自然选择下表达水平进化的蛋白质。在转录和翻译水平的基因调控的变化,被认为是参与人类表型多样性,包括疾病的易感性,并假设在人类进化中发挥了重要作用。虽然这一领域以前的大多数工作都集中在mRNA水平上,但蛋白质通常更直接地参与生物过程。此外,复杂的翻译调控机制可以影响蛋白质水平,而不依赖于转录本丰度。因此,在人类和非人类灵长类动物的蛋白质水平的变化的表征,预计将提供相当深入的基因组机制,可能在我们的进化史中发挥了重要作用。在这项研究中,我将(i)开发一个抗体微阵列平台,用于高通量测量多个灵长类物种的稳态蛋白质表达水平,(ii)使用这个平台比较人类,黑猩猩,(Pan troglodytes)和恒河猴(rhesus macaque)(Macaca mulatta)肝、肾、心、肺和睾丸组织,和(iii)检查种内和种间变异的比率,以鉴定其表达水平在灵长类动物间的稳定选择或人类谱系中的定向选择下进化的蛋白质。这些蛋白质可能参与人类疾病,例如当表达水平受到干扰时。此外,在稳态表达水平的适应性变化的蛋白质可能是重要的人类特异性性状的进化,这将是探索使用蛋白质的功能和表达模式和自然选择的组织分析。蛋白质表达水平的变化被认为与人类表型多样性(包括疾病易感性)有关,并可能在人类进化中发挥重要作用。这项研究将使用高通量技术来比较来自人类,黑猩猩和恒河猴的五种不同组织中的蛋白质表达水平,以鉴定表达水平(i)在三种灵长类物种中高度相似的蛋白质,以及(ii)沿着人类谱系显着增加或减少的蛋白质。这些蛋白质可能参与人类疾病,例如当表达水平受到干扰时,并且表达水平具有显著人类谱系变化的蛋白质可能在我们物种特有的身体特征的进化中很重要。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A rod cell marker of nocturnal ancestry.
夜间祖先的杆状细胞标记。
  • DOI:
    10.1016/j.jhevol.2009.09.007
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Perry,GeorgeH;Pickrell,JosephK
  • 通讯作者:
    Pickrell,JosephK
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George Herbert Perry其他文献

George Herbert Perry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George Herbert Perry', 18)}}的其他基金

Hunter-gatherer vs. agriculturalist growth and immune system functional genomics
狩猎采集者与农业者的生长和免疫系统功能基因组学
  • 批准号:
    9926888
  • 财政年份:
    2016
  • 资助金额:
    $ 5.05万
  • 项目类别:
Hunter-gatherer vs. agriculturalist growth and immune system functional genomics
狩猎采集者与农业者的生长和免疫系统功能基因组学
  • 批准号:
    9107983
  • 财政年份:
    2016
  • 资助金额:
    $ 5.05万
  • 项目类别:
Studying the evolution of gene regulation at the protein level in primates
研究灵长类动物蛋白质水平基因调控的进化
  • 批准号:
    7545152
  • 财政年份:
    2008
  • 资助金额:
    $ 5.05万
  • 项目类别:
Studying the evolution of gene regulation at the protein level in primates
研究灵长类动物蛋白质水平基因调控的进化
  • 批准号:
    7670430
  • 财政年份:
    2008
  • 资助金额:
    $ 5.05万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.05万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了